Chronic Use of β-Blockers and the Risk of Parkinson’s Disease

ConclusionsChronic use of β-blockers confers a time- and dose-dependent increased risk for Parkinson’s disease. In view of the available alternatives for β-blockers, their chronic use should be carefully reconsidered.

http://link.springer.com/10.1007/s40261-019-00771-y

Source: Clinical Drug Investigation - March 12, 2019 Category: Drugs & Pharmacology Source Type: research